Advance Planning and Compassionate Care Act of 1999
Read twice and referred to the Committee on Finance.
Congressional Research Service
Official summary
Version 00 · Introduced in Senate · Mar 16, 1999
Advance Planning and Compassionate Care Act of 1999 - Directs the Secretary of Health and Human Services to develop outcome standards and measures to evaluate health care program and project performance in providing quality end-of-life care and to report to Congress on such development. Requires the Secretary to study and report to Congress on: (1) the implementation of this Act; and (2) all matters relating to the creation of a national uniform policy on advance directives. Amends titles XVIII (Medicare) and XIX (Medicaid) of the Social Security Act, as amended by the Balanced Budget Act of 1997, with regard to advance directives in order to: (1) require service providers and eligible organizations to provide an appropriately trained professional for discussing advance directive issues with all adult individuals receiving medical care by or through such entities; and (2) ensure that an advance directive valid in one State will be honored in another State. Requires the Secretary, through the Health Care Financing Administration (HCFA), to: (1) establish and operate a clearinghouse and 24-hour toll-free telephone hotline to provide consumer information about advance directives and end-of-life decision making; (2) conduct ongoing evaluations of innovative health care programs that provide end-of-life care to Medicare beneficiaries who are seriously ill or who suffer from a medical condition that is likely to be fatal; and (3) conduct demonstration projects to develop new and innovative approaches to providing such end-of-life care. Directs the Secretary to report annually to Congress on the quality of end-of-life care under Medicare, together with any suggestions for legislation to improve the quality of such care. Provides for necessary funding of such evaluations, demonstration projects, and annual reports. Amends SSA title XVIII, as amended by the Balanced Budget Act of 1997, to provide for Medicare coverage of self-administered prescription drugs which are prescribed for the relief of chronic pain in patients with a life-threatening disease or condition.
No related bills are listed in this snapshot. This does not establish whether the proposal has appeared in earlier Congresses.
Source last updated: Aug 20, 2025. Consult Congress.gov for the current record.
AI Conversation Starters
Explore the bill from different angles
Choose a perspective, copy a prompt, and paste it into your preferred AI. Each prompt includes the bill version and available official source links, and asks for counterarguments as well as supporting evidence.
Neutral evidence review
Objective
Analyze S.628 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.
View full prompt & sources
Fairness and public impact
Progressive lens
Examine S.628 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.
View full prompt & sources
Institutions and government scope
Conservative lens
Examine S.628 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.
View full prompt & sources
Individual rights and government power
Liberty lens
Examine S.628 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.